Results 41 to 50 of about 868 (155)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Journal of Hepatocellular Carcinoma, 2020
Ajalaya Teyateeti,1,2 Armeen Mahvash,3 James P Long,4 Mohamed E Abdelsalam,3 Rony Avritscher,3 Beth Chasen,1 Ahmed O Kaseb,5 Joshua D Kuban,3 Ravi Murthy,3 Bruno C Odisio,3 Achiraya Teyateeti,6 Homer A Macapinlac,1 S Cheenu Kappadath7 1Department of ...
Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC   +12 more
doaj  

Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionuclide therapy [PDF]

, 2013
Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionulcide therapy Radiotherapy is the medical use of ionizing radiations to control or kill clonogenic ...
AVIGO, CINZIA
core   +1 more source

Radiological Loco‐Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is being diagnosed with increasing frequency worldwide. We performed a systematic review on radiofrequency (RFA), microwave (MWA), irreversible electroporation (IRE), trans‐arterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) in CCA. Thirty‐
Dimitrios Pallas, Claudia Campani, Olivier Sutter, Pierre Nahon, Nathalie Ganne‐Carrié, Olivier Seror, Jean‐Charles Nault   +6 more
wiley   +1 more source

Radial Dose Profile of a Y-90 Shpere

, 2018
############################################################## # RADIAL DOSE PROFILE OF A y-90 SHPERE (THERASPHERE) ############################################################## # # This file contains the raw data of a radial dose profile of a ...
Pérez-García, H (via Mendeley Data)
core   +1 more source

Radioembolization with Yttrium-90 resin microspheres in treatment of HCC with or without PVT: Initial Egyptian experience [PDF]

, 2013
Background/AimHepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Radioembolization with yttrium-90 (Y-90) microspheres is a new concept in radiation therapy for HCC.
El Ghazaly, Hesham A., Shebrya, Naglaa H., Hetta, Waleed M., Hetta, Osama M.   +3 more
core   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, Volume 27, Issue 1, January 2026.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source

Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Interventional radiology (IR) is a rapidly evolving medical field that combines advanced imaging with minimally invasive techniques for both diagnosis and treatment. Interventional oncology (IO), a subspecialty of IR, focuses on the minimally invasive, image‐guided intervention for cancer and cancer‐related conditions.
Mohamed E. Abdelsalam, Kamran Ahrar, Rahul A. Sheth, Ketan Y. Shah, Steven Yevich, Varshana Gurusamy, Bruno C. Odisio, Alda L. Tam, Armeen Mahvash, Peiman Habibollahi   +9 more
wiley   +1 more source

The Brazilian panorama for the calibration of Y-90 microspheres

Brazilian Journal of Radiation Sciences
The combination therapy approaches are gaining popularity, particularly the radiopharmaceutical therapy with external radiotherapy, immunotherapy or both.
Thamyra Cybelle Vieira dos Santos, Dayana Azeredo da Conceição, José Ubiratan Delgado   +2 more
doaj   +1 more source

Review Article: Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 6, Page 585-601, September 2025.
ICI is now the first‐line therapy for unresectable HCC and has revolutionised the management of advanced HCC and is now emerging as a modality for downstaging or bridging. The ideal timing of transplant after ICI should be at least 52 days. ABSTRACT Background Ablation, surgical resection and liver transplantation (LT) are curative therapies for ...
Anand V. Kulkarni, Amit G. Singal, K. Rajender Reddy   +2 more
wiley   +1 more source

Transarterial Radioembolization (TARE) Agents beyond Y-90-Microspheres [PDF]

, 2018
International audienceLiver malignancies, either primary tumours (mainly hepatocellular carcinoma and cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an increasing incidence. Among them, hepatocellular carcinoma (HCC)
Ardisson, V., Lepareur, Nicolas, Palard, X., Edeline, J., Garin, E., Loyer, P., Bouvry, C.   +6 more
core   +1 more source